About Cancer Research KI
Cancer Research KI serves as an overarching umbrella organisation for cancer research at Karolinska Institutet, conducted by some 250 research groups at multiple campuses and departments. The overall goal is to generate new scientific discoveries that can be rapidly translated into clinical practice for the benefit of patients and society.
Organisation
Cancer Research KI was formed 2019 as the Strategic Research Programme in Cancer (StratCan) and the KICancer network joined forces. The programme is supported by the government through the strategic initiatives.
Cancer Research KI Steering Board:
Jonas Bergh
Director Cancer Research KIKamila Czene
Co-Director Cancer Research KIUrban Lendahl
Co-Director Cancer Research KIMartin Bergö
ProfessorLisa Westerberg
Senior researcherYvonne Wengström
Professor/nurseIngemar Ernberg
Professor, seniorHans-Gustaf Ljunggren
ProfessorKlas Blomgren
Professor/senior physicianEva Hellström Lindberg
Professor/senior physicianOlli-Pekka Kallioniemi
ProfessorMaria Kasper
Senior researcherSonia Lain
ProfessorAndreas Lundqvist
GruppchefHarald Blegen
AssociatedBackground
In 2009 the Swedish Government designated in the Government Bill on Research Policy that 20 strategic research areas were to be prioritized; Cancer was one area. Cancer is represented nationally by three programmes: Cancer Research KI (formerly StratCan) at Karolinska Institutet, U-CAN (Universities of Uppsala & Umeå) and BioCare (Universities of Lund & Gothenburg).
Cancer as a strategic research area is motivated by the fact that cancer is one of the world's most common diseases and a major cause of death. In Sweden it is expected that cancer incidence will continue to rise and that cancer prevalence will double by 2030. New research strategies aiming at effective prevention and improved treatment are therefore urgently needed.